0
0
Industry
Geography
Report Type
Themes
Price
Publication date
Published Date
  • Company Insights

    New
    $350 | April 2024
    Company Insights
    New

    Stripe – Competitor Profile

    Stripe is a global payment services provider. Founded in 2010, the solution allows online merchants and vendors to accept payments for products and services offered through their own websites and mobile apps, as well as for those offered through third-party online marketplaces and platforms. Stripe works on all web-enabled devices. It has been deployed by a host of businesses globally, including online merchants, marketplaces, and platforms. The solution allows businesses to accept payments in over 135 currencies through more than...

  • Product Insights

    $2,000 | January 2024
    Product Insights

    Male Sexual Dysfunction – Drugs In Development, 2023

    Global Markets Direct’s, ‘Male Sexual Dysfunction - Drugs In Development, 2023’, provides an overview of the Male Sexual Dysfunction pipeline landscape. The report provides comprehensive information on the therapeutics under development for Male Sexual Dysfunction, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...

  • Product Insights

    $2,000 | January 2024
    Product Insights

    Encephalitis – Drugs In Development, 2023

    Global Markets Direct’s, ‘Encephalitis - Drugs In Development, 2023’, provides an overview of the Encephalitis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Encephalitis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...

  • Product Insights

    $2,000 | January 2024
    Product Insights

    Hypersecretory Conditions – Drugs In Development, 2023

    Global Markets Direct’s, ‘Hypersecretory Conditions - Drugs In Development, 2023’, provides an overview of the Hypersecretory Conditions pipeline landscape. The report provides comprehensive information on the therapeutics under development for Hypersecretory Conditions, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...

  • Product Insights

    $2,000 | January 2024
    Product Insights

    Insulin Resistance – Drugs In Development, 2023

    Global Markets Direct’s, ‘Insulin Resistance - Drugs In Development, 2023’, provides an overview of the Insulin Resistance pipeline landscape. The report provides comprehensive information on the therapeutics under development for Insulin Resistance, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...

  • Product Insights

    $2,000 | January 2024
    Product Insights

    Methylmalonic Acidemia – Drugs In Development, 2023

    Global Markets Direct’s, ‘Methylmalonic Acidemia - Drugs In Development, 2023’, provides an overview of the Methylmalonic Acidemia pipeline landscape. The report provides comprehensive information on the therapeutics under development for Methylmalonic Acidemia, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...

  • Product Insights

    $2,000 | January 2024
    Product Insights

    Myocarditis – Drugs In Development, 2023

    Global Markets Direct’s, ‘Myocarditis - Drugs In Development, 2023’, provides an overview of the Myocarditis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Myocarditis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...

  • Product Insights

    $2,000 | January 2024
    Product Insights

    Osteonecrosis – Drugs In Development, 2023

    Global Markets Direct’s, ‘Osteonecrosis - Drugs In Development, 2023’, provides an overview of the Osteonecrosis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Osteonecrosis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...

  • Product Insights

    $2,000 | January 2024
    Product Insights

    Pouchitis – Drugs In Development, 2023

    Global Markets Direct’s, ‘Pouchitis - Drugs In Development, 2023’, provides an overview of the Pouchitis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Pouchitis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...

  • Product Insights

    $2,000 | January 2024
    Product Insights

    Pulmonary Sarcoidosis – Drugs In Development, 2023

    Global Markets Direct’s, ‘Pulmonary Sarcoidosis - Drugs In Development, 2023’, provides an overview of the Pulmonary Sarcoidosis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Pulmonary Sarcoidosis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...

Looking to stay on top of industry & market trends?

Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.